Literature DB >> 11297809

Firing properties of identified superior laryngeal neurons in the nucleus ambiguus in the rat.

M Irnaten1, J Wang, D Mendelowitz.   

Abstract

Superior laryngeal motoneurons control muscles in the larynx and recent work has shown they also have axon collaterals that project to cardiac vagal neurons in the nucleus ambiguus. The present study was undertaken to identify and examine the firing properties of superior laryngeal neurons (SLNs) in the rat. SLNs typically fired spontaneously and repetitively at a rate of 4-7 Hz. The firing was continuous and showed little bursting activity. Firing evoked afterhyperpolarizations were insensitive to apamin but blocked by charybdotoxin. The voltage-gated currents in SLNs consist of a TTX-sensitive Na current and a 4-aminopyridine sensitive K current. It is likely that the activity of these neurons not only control respiratory laryngeal muscles, but may also provide an interaction between the respiratory system and the control of the heart rate.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11297809     DOI: 10.1016/s0304-3940(01)01693-7

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  3 in total

1.  Electrophysiological properties of laryngeal motoneurones in rats submitted to chronic intermittent hypoxia.

Authors:  Davi J A Moraes; Benedito H Machado
Journal:  J Physiol       Date:  2015-01-05       Impact factor: 5.182

2.  Adrenergic agonist induces rhythmic firing in quiescent cardiac preganglionic neurons in nucleus ambiguous via activation of intrinsic membrane excitability.

Authors:  Isamu Aiba; Jeffrey L Noebels
Journal:  J Neurophysiol       Date:  2019-01-30       Impact factor: 2.714

3.  Orexin-A Excites Airway Vagal Preganglionic Neurons via Activation of Orexin Receptor Type 1 and Type 2 in Rats.

Authors:  Yonghua Chen; Yuhong Guo; Xianxia Yan; Ming Zeng; Hong Chen; Dongying Qiu; Jijiang Wang
Journal:  Front Cell Neurosci       Date:  2019-10-23       Impact factor: 5.505

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.